Sign up for our Newsletter

Whiz Midstream

Especially in the Healthcare Industry where a service and an analysis is being provided it is essential to use the clinically best and most effective method immediately. 70% of all health care is pathology based and Urine sample collection, on which the analysis will be based and in turn on which the healthcare will be based is no exception.

Because the urine sample is the basis of so much in healhcare (including MRSA) and even when not the importance of reducing spillage to spread diseases (eg with c-difficile) the Whiz Midstream offers multiple benefits to:

• Patients
• Staff
• Clinicians
• GP's
• State Hospitals/NHS
• Private hospitals
• Pathology Labs
• General Health care

First and foremost it is we believe the only current IVD (in vitro diagnostic) product that is fully regulatory compliant with all current health and safety regulations that ensure the health and safety of the patient, and the professional medical staff. Amongst others the Midstream also offers:

General savings and financial benefits of the Whiz Midstream

It should not be avoided that today costs are an issue. No one doubts that there is a substantial cost for every urine test, A figure of £28.50 is an accepted figure taking into account direct consumables and associated costs. Not included would be the costs of inappropriate anti-biotics or other health care associated costs, litigation or malpractise suits which could run to £100,000 let alone the loss to the patient. Also to be considered is the damage to the practioner involved in such a case of working or supplying equipment contrary to Regulations which could mean a loss of a job, wasted training etc etc.

Indeed in ante-natal, the human cost is far higher, as in the case of a fatality or major health implication as can so easily occurred in ante-natal cases where a UTI is not detected or the catching of issues of cross infection due to urine contamination
The reduction in the number of re-tests and associated costs create considerable financial benefits to the healthcare provider. The potential savings to the NHS on microbiological samples alone would be a minimum of £23 million**, with total savings of some £40-80 million. Individually, savings could be from a minimum of £1.28 per to £8.00 per test (from areas where contamination is known to be as high as 56%) after deducting the cost of the device. Further financial benefits such as general hospital expenditure are not included.

Hospitals

Direct Benefits: Lower staff costs in collection centres. Lower cleaning costs in both time and materials. Lower contamination rates mean: less time spent on microscopy, fewer full cultures, fewer direct sensitivity tests, less time spent analysing results. Fewer false positives. Better detection of UTIs. Less coldroom and bench space required. Faster, more accurate service. Greater competitive edge.

Patient benefits

• Significantly better results and therefore signifcantly better healthcare
• Preference and convenience - Substantial majority of patients preferred Whiz Midstream to conventional techniques
• Less messy, less hassle and less complicated
• No need to stop/start
• 70.39%* first time users rated Midstream improvement over conventional method, 100 % of second time users

General healthcare benefits

• Standardisation of mid-stream urine collection
• Improved working environment for staff
• Adherence to BSOP41 and COSSH Guidelines
• Removal of dependence on the patient to provide a good MSU
• Represents best medical practice

General Practitioners

• Cost Saving
• Better Service
• More Accurate Diagnosis

Comments by patients

• "No uncomfortable pauses or wet hands"
• "Clean and simple"
• "Easy... very practical"
• "No weeing on hands and down bottle"
• "Why don't doctor's surgeries use these?"
• "No mess, no spillages, no stop and start"